These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16227051

  • 1. Growth hormone deficiency and HIV infection.
    Weinberg GA, Jospe N.
    J Pediatr; 2005 Oct; 147(4):559-60. PubMed ID: 16227051
    [No Abstract] [Full Text] [Related]

  • 2. Growth hormone deficiency in HIV-infected children following successful treatment with highly active antiretroviral therapy.
    Watson DC, Counts DR.
    J Pediatr; 2004 Oct; 145(4):549-51. PubMed ID: 15480383
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone deficiency in children with myelomeningocele (MMC)--effects of growth hormone treatment.
    Trollmann R, Strehl E, Dörr HG.
    Eur J Pediatr Surg; 1997 Dec; 7 Suppl 1():58-9. PubMed ID: 9497133
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of growth hormone therapy in a 14-years-old boy with Crohn's disease and growth hormone deficiency].
    Szalecki M, Mierzejewska-Rudnicka A, Nawrotek J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Dec; 12(2):140-3. PubMed ID: 16813721
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone therapy.
    Bhatia V.
    Indian Pediatr; 1997 Aug; 34(8):675-9. PubMed ID: 9492395
    [No Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 7. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B, Ziółkowska H, Majcher A, Roszkowska-Blaim M.
    Przegl Lek; 2006 Oct; 63 Suppl 3():153-5. PubMed ID: 16898517
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Jan; 12(1):31-4. PubMed ID: 16704859
    [Abstract] [Full Text] [Related]

  • 10. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

  • 11. [Growth follow-up of SGA children after 3 years of GH treatment].
    Edouard T, Oliver I, Jouret B, Lounis N, Moulin P, Pienkowski C, Elefterion M, Salles JP, Tauber M.
    Arch Pediatr; 2008 Feb; 15(2):115-21. PubMed ID: 18207714
    [Abstract] [Full Text] [Related]

  • 12. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S.
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract] [Full Text] [Related]

  • 13. Predicting growth in response to growth hormone treatment.
    Ranke MB, Lindberg A.
    Growth Horm IGF Res; 2009 Feb; 19(1):1-11. PubMed ID: 18824380
    [Abstract] [Full Text] [Related]

  • 14. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Feb; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of current growth hormone treatments and future therapies.
    Ross R.
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
    [Abstract] [Full Text] [Related]

  • 16. Monitoring of concordance in growth hormone therapy.
    Kapoor RR, Burke SA, Sparrow SE, Hughes IA, Dunger DB, Ong KK, Acerini CL.
    Arch Dis Child; 2008 Feb; 93(2):147-8. PubMed ID: 17768149
    [Abstract] [Full Text] [Related]

  • 17. Long-term growth hormone therapy in an adolescent boy with 45,X/46,XidicY(p11).
    Guevarra FM, Nimkarn S, New MI, Lin-Su K.
    J Pediatr; 2009 Nov; 155(5):752-5.e1-3. PubMed ID: 19840619
    [Abstract] [Full Text] [Related]

  • 18. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME, Karlsson H.
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [Abstract] [Full Text] [Related]

  • 19. [Growth hormone therapy].
    Krysiak R, Okopień B, Gdula-Dymek A.
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [Abstract] [Full Text] [Related]

  • 20. European perspective on treatment approaches for growth failure.
    Wit JM, Bang P.
    Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():862-8. PubMed ID: 18438332
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.